Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > 06821 ASYMCHEM > Detailed Quotes

06821 ASYMCHEM

Watchlist
129.600
-2.900-2.19%
Closed  02/03 16:08 CCT
High
135.000
Open
135.000
Turnover
24.30M
Low
127.300
Pre Close
132.500
Volume
187.62K
Market Cap
47.95B
P/E(TTM)
14.01
52wk High
205.044
Shares
369.98M
P/E(Static)
36.66
52wk Low
80.350
Float Cap
3.57B
Bid/Ask %
60.66%
Historical High
276.473
Shs Float
27.55M
Volume Ratio
0.74
Historical Low
80.350
Dividend TTM
0.672
Div Yield TTM
0.672
P/B
2.88
Dividend LFY
0.52%
Div Yield LFY
0.52%
Turnover Ratio
0.68%
Amplitude
5.81%
Avg Price
129.540
Lot Size
100
Float Cap
3.57B
Bid/Ask %
60.66%
Historical High
276.473
Shs Float
27.55M
Volume Ratio
0.74
Historical Low
80.350
Dividend TTM
0.672
P/B
2.88
Dividend LFY
0.52%
Turnover Ratio
0.68%
Amplitude
5.81%
Avg Price
129.540
Lot Size
100
Price Forecast

News

Comment

Company Overview More
The company (stock code: 002821.SZ/6821.HK) is a world-leading CDMO company, providing high-quality one-stop services for R&D and production of new drugs worldwide. It is our mission to accelerate the launch of new drugs and extend the quality of life. Relying on continuous technological innovation, we provide domestic and foreign pharmaceutical companies and biotechnology companies with one-stop CMC services for the full life cycle of drugs to accelerate the development and application of new drugs. The company is a world-leading, technology-driven CDMO one-stop integrated service provider. Accelerate clinical research and commercial application of innovative drugs by providing domestic and foreign pharmaceutical companies and biotechnology companies with one-stop CMC services for the full life cycle of drugs and efficient and high-quality R&D and production services. By providing domestic and foreign pharmaceutical companies and biotechnology companies with one-stop CMC services for the full life cycle of pharmaceuticals, efficient and high-quality R&D and production services in 2019, the company won the “2018 Best Partner for the Transformation and Upgrading of Chinese Pharmaceutical Enterprises”. A total of 6 winning enterprises/institutions were selected in this selection. As the only pharmaceutical CDMO company on the list, the company won the award through a hierarchical screening process for its excellent quality and service, good reputation and reputation - this is another time the company won this honor. It won the “China Pharmaceutical Industry Top 100” and “Top 20 Pharmaceutical Outsourcing Companies in China” awards in the “2018 China Pharmaceutical Industry Most Influential List” issued by the Pharmaceutical Chamber of Commerce of the All-China Federation of Industry and Commerce, fully demonstrating the company's strong competitiveness and strong growth as an industry benchmark.
CEO: Hao Hong
Market: Hong Kong motherboard
Listing Date: 12/10/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist